Transitional cell carcinoma risk factors: Difference between revisions

Jump to navigation Jump to search
Line 6: Line 6:


== Risk Factors ==
== Risk Factors ==
*Smoking:<ref>Risk factors for bladder cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/renal-pelvis-and-ureter/risks/?region=ab Accessed on February 10, 2016 </ref>
Common risk factors in the development of transitional cell carcinoma are:<ref name=Canada>Risk factors for bladder cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/renal-pelvis-and-ureter/risks/?region=ab Accessed on February 10, 2016 </ref><ref name="KirkaliTuzel2003">{{cite journal|last1=Kirkali|first1=Ziya|last2=Tuzel|first2=Emre|title=Transitional cell carcinoma of the ureter and renal pelvis|journal=Critical Reviews in Oncology/Hematology|volume=47|issue=2|year=2003|pages=155–169|issn=10408428|doi=10.1016/S1040-8428(03)00079-9}}</ref>
*Smoking
:*Smoking tobacco is the strongest risk factor for developing cancer of the renal pelvis or ureter.
:*Smoking tobacco is the strongest risk factor for developing cancer of the renal pelvis or ureter.
:*Risk increases with the length of time a person smokes and with the number of cigarettes smoked.
:*Risk increases with the length of time a person smokes and with the number of cigarettes smoked.

Revision as of 15:23, 19 February 2016

Transitional cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Transitional cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Cystoscopy and Bladder Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Transitional cell carcinoma risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transitional cell carcinoma risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transitional cell carcinoma risk factors

CDC on Transitional cell carcinoma risk factors

Transitional cell carcinoma risk factors in the news

Blogs on Transitional cell carcinoma risk factors

Directions to Hospitals Treating Transitional cell carcinoma

Risk calculators and risk factors for Transitional cell carcinoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Common risk factors in the development of transitional cell carcinoma are smoking, occupational exposure to chemicals, chronic bladder irritation, chemotherapy, radiation therapy, arsenic, personal history of cancer in the urinary tract, congenital bladder anomalies, and aristolochic acids.

Risk Factors

Common risk factors in the development of transitional cell carcinoma are:[1][2]

  • Smoking
  • Smoking tobacco is the strongest risk factor for developing cancer of the renal pelvis or ureter.
  • Risk increases with the length of time a person smokes and with the number of cigarettes smoked.
  • Phenacetin
  • Human papilloma virus
  • Balkan nephropathy
  • Occupational exposure to chemicals
  • Textiles
  • Rubber
  • Paint
  • Leather
  • Dye
  • Print
  • Metal
  • Machining
  • Plastics
  • Transportation
  • Chronic bladder irritation
  • Trauma
  • Aristolochic acids

References

  1. Risk factors for bladder cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/renal-pelvis-and-ureter/risks/?region=ab Accessed on February 10, 2016
  2. Kirkali, Ziya; Tuzel, Emre (2003). "Transitional cell carcinoma of the ureter and renal pelvis". Critical Reviews in Oncology/Hematology. 47 (2): 155–169. doi:10.1016/S1040-8428(03)00079-9. ISSN 1040-8428.

Template:WH Template:WS